Familial generalized lentiginosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:231040OMIM:151001L81.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial generalized lentiginosis is a rare inherited skin condition characterized by the widespread presence of lentigines — small, flat, brown to dark brown pigmented spots — distributed diffusely across the body. Unlike lentigines associated with sun exposure, these spots appear in both sun-exposed and non-sun-exposed areas, including the trunk, extremities, and sometimes the face. The condition typically manifests in childhood and the number of lentigines may increase over time. Familial generalized lentiginosis is distinguished from other lentiginosis syndromes (such as Peutz-Jeghers syndrome, LEOPARD syndrome, or Carney complex) by the absence of associated systemic abnormalities — affected individuals generally do not have cardiac, endocrine, or gastrointestinal involvement. The condition is primarily a cosmetic concern, and the lentigines themselves are benign melanocytic lesions without significant risk of malignant transformation. Diagnosis is clinical, based on the characteristic widespread distribution of lentigines and a positive family history. Histologically, the lesions show elongation of rete ridges with increased numbers of melanocytes and melanin deposition in the basal layer of the epidermis. There is no specific curative treatment for familial generalized lentiginosis. Management is largely supportive and cosmetic, with options including laser therapy (such as Q-switched lasers), topical depigmenting agents, and cryotherapy for individual lesions if desired for aesthetic reasons. Sun protection is generally recommended to prevent further pigmentary changes. Genetic counseling may be offered to affected families.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Familial generalized lentiginosis.

View clinical trials →

No actively recruiting trials found for Familial generalized lentiginosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial generalized lentiginosis community →

No specialists are currently listed for Familial generalized lentiginosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial generalized lentiginosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial generalized lentiginosisForum →

No community posts yet. Be the first to share your experience with Familial generalized lentiginosis.

Start the conversation →

Latest news about Familial generalized lentiginosis

No recent news articles for Familial generalized lentiginosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial generalized lentiginosis

What is Familial generalized lentiginosis?

Familial generalized lentiginosis is a rare inherited skin condition characterized by the widespread presence of lentigines — small, flat, brown to dark brown pigmented spots — distributed diffusely across the body. Unlike lentigines associated with sun exposure, these spots appear in both sun-exposed and non-sun-exposed areas, including the trunk, extremities, and sometimes the face. The condition typically manifests in childhood and the number of lentigines may increase over time. Familial generalized lentiginosis is distinguished from other lentiginosis syndromes (such as Peutz-Jeghers synd

How is Familial generalized lentiginosis inherited?

Familial generalized lentiginosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Familial generalized lentiginosis typically begin?

Typical onset of Familial generalized lentiginosis is childhood. Age of onset can vary across affected individuals.